STUDY_ACCESSION	ACTUAL_COMPLETION_DATE	ACTUAL_ENROLLMENT	ACTUAL_START_DATE	AGE_UNIT	BRIEF_DESCRIPTION	BRIEF_TITLE	CLINICAL_TRIAL	CONDITION_STUDIED	DCL_ID	DESCRIPTION	DOI	ENDPOINTS	GENDER_INCLUDED	HYPOTHESIS	INITIAL_DATA_RELEASE_DATE	INITIAL_DATA_RELEASE_VERSION	INTERVENTION_AGENT	LATEST_DATA_RELEASE_DATE	LATEST_DATA_RELEASE_VERSION	MAXIMUM_AGE	MINIMUM_AGE	OBJECTIVES	OFFICIAL_TITLE	SPONSORING_ORGANIZATION	TARGET_ENROLLMENT	TYPE	WORKSPACE_ID
SDY202		79	2009-01-01 00:00:00	Years	To study the plasmablast response to monovalent inactivated 2009 pandemic pH1N1 vaccine	Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine	Y	Peripheral plasmablast response to influenza vaccines at day 7 after vaccination	2	To study the plasmablast response to monovalent inactivated 2009 pandemic pH1N1 vaccine	10.21430/M3LS2SRM8M	PPAb titer by Elisa	Female, Male, Not Specified	Inactivated influenza pH1N1 vaccine induced different plasmablast response in different age groups	2015-02-18 00:00:00	DR12	Monovalent inactivated pH1N1 vaccine	2015-02-18 00:00:00	DR12	81	18	To measure plasmablast resposne to monovalent inactivated influenza pH1N1 vaccines	Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine	NIAID		Interventional	2883
